: Asthma is now recognized as an inflammatory disease of the airways. Eosinophils, neutrophils, macrophages and lymphocytes, are also recruited into the airways. The arachidonic acid derivative leukotriene B4 (LTB4) and its receptors are important mediators of leukocyte chemotaxis. LTB4 signaling has been implicated in the pathogenesis of asthma and in a murine model of this disorder. However, the precise role of the LTB4 receptors, BLTR1 and BLTR2, in the pathobiology of asthma is incompletely known. Our laboratory has recently generated a mouse strain with a targeted deletion in the gene that codes for BLTR1 (BLTR1-/-). Preliminary experiments using this mouse strain in a murine model of asthma have shown a reduction in eosinophils recruited into the airways. Our hypothesis is that LTB4 is an important chemoattractant for leukocytes in this model of asthma and that its actions are mediated primarily through the BLTR1 receptor. We also propose that LTB4 signaling is important in the development of airway remodeling. Specifically we seek to determine the following: 1) if BLTR1 signaling is important for the recruitment of eosinophils, neutrophils, and macrophages in this model of asthma; 2) if BLTR1 effects the recruitment and profile of T lymphocytes in the airways and lymph nodes in this model; 3) if BLTR1 signaling is important in airways hyperreactivity and mucous production; 4) if BLTR1 signaling effects airway remodeling in a chronic asthma model; 5) if the newly described receptor BLTR2 has any functional role in this murine model of asthma. Using a model of asthma in BLTR1-/- mice we hope to precisely define the role of BLTR1 in asthma pathogenesis. Repeat experiments in the presence of a BLTR2 antagonist will also allow characterization of the role of this receptor in asthma.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32AI050399-03
Application #
6608596
Study Section
Special Emphasis Panel (ZRG1-IMB (20))
Program Officer
Prograis, Lawrence J
Project Start
2002-07-01
Project End
2003-08-01
Budget Start
2003-07-01
Budget End
2003-08-01
Support Year
3
Fiscal Year
2003
Total Cost
$6,984
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Harris, R Scott; Venegas, José G; Wongviriyawong, Chanikarn et al. (2011) 18F-FDG uptake rate is a biomarker of eosinophilic inflammation and airway response in asthma. J Nucl Med 52:1713-20
Medoff, Benjamin D; Tager, Andrew M; Jackobek, Ryan et al. (2006) Antibody-antigen interaction in the airway drives early granulocyte recruitment through BLT1. Am J Physiol Lung Cell Mol Physiol 290:L170-8
Tager, Andrew M; Bromley, Shannon K; Medoff, Benjamin D et al. (2003) Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 4:982-90
Mathew, Anuja; Medoff, Benjamin D; Carafone, Andrew D et al. (2002) Cutting edge: Th2 cell trafficking into the allergic lung is dependent on chemoattractant receptor signaling. J Immunol 169:651-5
Medoff, Benjamin D; Sauty, Alain; Tager, Andrew M et al. (2002) IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J Immunol 168:5278-86